1,4-立方烷二羧酸 | 32846-66-5

• 物质功能分类: 有机原料 - 羧酸类化合物及衍生物
• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 中文名称: 1,4-立方烷二羧酸
• 英文名称: cubane-1,4-dicarboxylic acid
• 英文别名: 1,4-cubanedicarboxylic acid
• CAS: 32846-66-5
• 化学式: C₁₀H₈O₄
• mdl: MFCD08458496
• 分子量: 192.171
• InChiKey: JFKXMJUMOJJTCQ-UHFFFAOYSA-N

物化性质

• 熔点：
  224°C
• 沸点：
  457.4±45.0 °C(Predicted)
• 密度：
  2.401±0.06 g/cm3(Predicted)
• 闪点：
  244.6℃

计算性质

• 辛醇/水分配系数(LogP)：
  -0.7
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.8
• 拓扑面积：
  74.6
• 氢给体数：
  2
• 氢受体数：
  4

安全信息

• 海关编码：
  2918990090
• WGK Germany：
  3
• 危险性防范说明：
  P261,P264,P270,P271,P280,P301+P312,P302+P352,P304+P340,P305+P351+P338,P312,P321,P330,P332+P313,P362,P403+P233,P405,P501
• 危险性描述：
  H302,H315,H319,H335
• 储存条件：
  室温、密闭保存，并置于干燥处。

SDS

---

SECTION 1: Identification of the substance/mixture and of the company/undertaking
Product identifiers
Product name : 1,4-Cubanedicarboxylic acid
REACH No. : A registration number is not available for this substance as the substance
or its uses are exempted from registration, the annual tonnage does not
require a registration or the registration is envisaged for a later
registration deadline.
CAS-No. : 32846-66-5
Relevant identified uses of the substance or mixture and uses advised against
Identified uses : Laboratory chemicals, Manufacture of substances

---

SECTION 2: Hazards identification
Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008
Acute toxicity, Oral (Category 3), H301
For the full text of the H-Statements mentioned in this Section, see Section 16.
Classification according to EU Directives 67/548/EEC or 1999/45/EC
T Toxic R25
For the full text of the R-phrases mentioned in this Section, see Section 16.
Label elements
Labelling according Regulation (EC) No 1272/2008
Pictogram
Signal word Danger
Hazard statement(s)
H301 Toxic if swallowed.
Precautionary statement(s)
P301 + P310 IF SWALLOWED: Immediately call a POISON CENTER or doctor/
physician.
Supplemental Hazard none
Statements
Other hazards - none

---

SECTION 3: Composition/information on ingredients
Substances
Formula : C10H8O4
Molecular Weight : 192,17 g/mol
CAS-No. : 32846-66-5
Hazardous ingredients according to Regulation (EC) No 1272/2008
Component Classification Concentration
1,4-Cubanedicarboxylic acid
CAS-No. 32846-66-5 Acute Tox. 3; H301 <= 100 %
Hazardous ingredients according to Directive 1999/45/EC
Component Classification Concentration
1,4-Cubanedicarboxylic acid
CAS-No. 32846-66-5 T, R25 <= 100 %
For the full text of the H-Statements and R-Phrases mentioned in this Section, see Section 16

---

SECTION 4: First aid measures
Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Take victim immediately to hospital. Consult a physician.
In case of eye contact
Flush eyes with water as a precaution.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
Most important symptoms and effects, both acute and delayed
The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in
section 11
Indication of any immediate medical attention and special treatment needed
no data available

---

SECTION 5: Firefighting measures
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available

---

SECTION 6: Accidental release measures
Personal precautions, protective equipment and emergency procedures
Wear respiratory protection. Avoid dust formation. Avoid breathing vapours, mist or gas. Ensure
adequate ventilation. Evacuate personnel to safe areas. Avoid breathing dust.
For personal protection see section 8.
Environmental precautions
Prevent further leakage or spillage if safe to do so. Do not let product enter drains.
Methods and materials for containment and cleaning up
Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed
containers for disposal.
Reference to other sections
For disposal see section 13.

---

SECTION 7: Handling and storage
Precautions for safe handling
Avoid contact with skin and eyes. Avoid formation of dust and aerosols.
Provide appropriate exhaust ventilation at places where dust is formed.
For precautions see section 2.2.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Specific end use(s)
Apart from the uses mentioned in section 1.2 no other specific uses are stipulated

---

SECTION 8: Exposure controls/personal protection
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
Avoid contact with skin, eyes and clothing. Wash hands before breaks and immediately after handling
the product.
Personal protective equipment
Eye/face protection
Face shield and safety glasses Use equipment for eye protection tested and approved under
appropriate government standards such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Body Protection
Complete suit protecting against chemicals, The type of protective equipment must be selected
according to the concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
Where risk assessment shows air-purifying respirators are appropriate use a full-face particle
respirator type N99 (US) or type P2 (EN 143) respirator cartridges as a backup to engineering
controls. If the respirator is the sole means of protection, use a full-face supplied air respirator. Use
respirators and components tested and approved under appropriate government standards such
as NIOSH (US) or CEN (EU).
Control of environmental exposure
Prevent further leakage or spillage if safe to do so. Do not let product enter drains.

---

SECTION 9: Physical and chemical properties
Information on basic physical and chemical properties
a) Appearance Form: solid
b) Odour no data available
c) Odour Threshold no data available
d) pH no data available
e) Melting point/freezing no data available
point
f) Initial boiling point and no data available
boiling range
g) Flash point no data available
h) Evapouration rate no data available
i) Flammability (solid, gas) no data available
j) Upper/lower no data available
flammability or
explosive limits
k) Vapour pressure no data available
l) Vapour density no data available
m) Relative density no data available
n) Water solubility no data available
o) Partition coefficient: n- log Pow: 0,832
octanol/water
p) Auto-ignition no data available
temperature
q) Decomposition no data available
temperature
r) Viscosity no data available
s) Explosive properties no data available
t) Oxidizing properties no data available
Other safety information
no data available

---

SECTION 10: Stability and reactivity
Reactivity
no data available
Chemical stability
Stable under recommended storage conditions.
Possibility of hazardous reactions
no data available
Conditions to avoid
no data available
Incompatible materials
Strong oxidizing agents
Hazardous decomposition products
Other decomposition products - no data available
In the event of fire: see section 5

---

SECTION 11: Toxicological information
Information on toxicological effects
Acute toxicity
no data available
no data available
Skin corrosion/irritation
no data available
no data available
Serious eye damage/eye irritation
no data available
no data available
Respiratory or skin sensitisation
no data available
no data available
Germ cell mutagenicity
no data available
no data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
no data available
Specific target organ toxicity - single exposure
no data available
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Additional Information
RTECS: Not available
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.

---

SECTION 12: Ecological information
Toxicity
no data available
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
PBT/vPvB assessment not available as chemical safety assessment not required/not conducted
Other adverse effects
no data available
no data available

---

SECTION 13: Disposal considerations
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company. Dissolve or mix the material
with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber.
Contaminated packaging
Dispose of as unused product.

---

SECTION 14: Transport information
UN number
ADR/RID: 2810 IMDG: 2810 IATA: 2810
UN proper shipping name
ADR/RID: TOXIC LIQUID, ORGANIC, N.O.S. (1,4-Cubanedicarboxylic acid)
IMDG: TOXIC LIQUID, ORGANIC, N.O.S. (1,4-Cubanedicarboxylic acid)
IATA: Toxic liquid, organic, n.o.s. (1,4-Cubanedicarboxylic acid)
Transport hazard class(es)
ADR/RID: 6.1 IMDG: 6.1 IATA: 6.1
Packaging group
ADR/RID: III IMDG: III IATA: III
Environmental hazards
ADR/RID: no IMDG Marine pollutant: no IATA: no
Special precautions for user
no data available

---

SECTION 15: Regulatory information
This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006.
Safety, health and environmental regulations/legislation specific for the substance or mixture
no data available
Chemical Safety Assessment
For this product a chemical safety assessment was not carried out

---

SECTION 16: Other information
Full text of H-Statements referred to under sections 2 and 3.
Acute Tox. Acute toxicity
H301 Toxic if swallowed.
Full text of R-phrases referred to under sections 2 and 3
T Toxic
R25 Toxic if swallowed.
Further information
Copyright 2014 Co. LLC. License granted to make unlimited paper copies for internal use
only.
The above information is believed to be correct but does not purport to be all inclusive and shall be
used only as a guide. The information in this document is based on the present state of our knowledge
and is applicable to the product with regard to appropriate safety precautions. It does not represent any
guarantee of the properties of the product. Corporation and its Affiliates shall not be held
liable for any damage resulting from handling or from contact with the above product. See
and/or the reverse side of invoice or packing slip for additional terms and conditions of sale.

反应信息

• 作为反应物：
  描述：

  1,4-立方烷二羧酸 在 甲醇 、 sodium hydroxide 作用下， 以 四氢呋喃 为溶剂， 以50 %的产率得到4-甲氧羰基立方烷羧酸
  参考文献：
  名称：

  二苯甲酮作为一种廉价有效的光敏剂用于光催化合成立方烷-1,4-二甲酸二甲酯

  摘要：

  1,4-二羧酸二甲酯合成中的关键分子内 [2 + 2] 光化学环加成步骤是用亚化学计量的光敏剂二苯甲酮进行的。该反应通过三重激发态二苯甲酮和众所周知的立方烷前体二烯之间的右旋能量转移过程进行。使用廉价且广泛使用的二苯甲酮作为光敏剂，可以使用比传统光化学过程更低能量的光。

  DOI：

  10.1039/d3ob00231d
• 作为产物：
  描述：

  4-甲氧羰基立方烷羧酸 在 水 、 sodium hydroxide 作用下， 以 甲醇 为溶剂， 反应 4.5h， 以91%的产率得到1,4-立方烷二羧酸
  参考文献：
  名称：

  具有可生物降解副产物的无金属高效，通用和简便的碘脱羧方法

  摘要：

  据报道，在不使用重金属或强氧化剂的情况下，将脂肪族和芳香族羧酸一般转化为有机碘化物的新颖，有效和鲁棒的方法的开发。在辐照条件下，可商购获得的N-碘酰胺既用于引发反应，又用于卤素的捐赠。产品的分离非常简单，主要副产物作为水溶性生物可降解材料被去除。

  DOI：

  10.1002/adsc.201100145

文献信息

• [EN] PROCESS FOR THE PREPARATION OF IODIDES<br/>[FR] PROCÉDÉ DE PRÉPARATION D'IODURES
  申请人：TECHNION R & D FOUNDATION LTD

  公开号：WO2011154953A1

  公开（公告）日：2011-12-15

  This invention is directed to a process for the preparation of high yield alkyl or aryl iodide from its corresponding carboxylic acid using N-iodo amides.

  这项发明涉及利用N-碘酰胺从相应的羧酸制备高产量的烷基或芳基碘化物的过程。
• BIFUNCTIONAL CYTOTOXIC AGENTS CONTAINING THE CTI PHARMACOPHORE
  申请人：Pfizer Inc.

  公开号：US20160271270A1

  公开（公告）日：2016-09-22

  The present invention is directed to novel bifunctional CTI-CTI and CBI-CTI dimers of the formula: F 1 -L 1 -T-L 2 -F 2 where F 1 , L 1 , T, L 2 and F 2 are as defined herein, useful for the treatment for proliferative diseases, where the inventive dimers can function as stand-alone drugs, payloads in antibody-drug-conjugates (ADCs), and linker-payload compounds useful in connection with the production or administration of such ADCs; and to compositions including the aforementioned dimers, linker-payloads and ADCs, and methods for using these dimers, linker-payloads and ADCs, to treat pathological conditions including cancer.

  本发明涉及新颖的具有双重功能的CTI-CTI和CBI-CTI二聚物，其公式为： F1-L1-T-L2-F2 其中F1、L1、T、L2和F2如本文所述定义，用于治疗增殖性疾病，其中发明的二聚物可以作为独立药物、抗体药物偶联物（ADCs）中的有效载荷以及与生产或施用此类ADCs相关的连接器有效载荷化合物；以及包括前述二聚物、连接器有效载荷和ADCs的组合物，以及使用这些二聚物、连接器有效载荷和ADCs治疗包括癌症在内的病理状况的方法。
• [EN] MODULATORS OF THE INTEGRATED STRESS PATHWAY<br/>[FR] MODULATEURS DE LA VOIE DE RÉPONSE INTÉGRÉE AU STRESS
  申请人：CALICO LIFE SCIENCES LLC

  公开号：WO2019090069A1

  公开（公告）日：2019-05-09

  Provided herein are compounds, compositions, and methods useful for the modulation of elF2B, for modulating the integrated stress response (ISR) and for treating related diseases; disorders and conditions.

  本文提供了用于调节elF2B、调节综合应激反应（ISR）以及治疗相关疾病、疾病和症状的化合物、组合物和方法。
• Structurally Diverse Acyl Bicyclobutanes: Valuable Strained Electrophiles
  作者：Brett D. Schwartz、Meng Yao Zhang、Riley H. Attard、Michael G. Gardiner、Lara R. Malins

  DOI：10.1002/chem.201905539

  日期：2020.3.2

  This work reports two efficient pathways for the rapid preparation of over 20 structurally diverse BCB ketones, encompassing simple alkyl and aryl derivatives, as well as unprecedented amino acid, dipeptide, bioisostere, and bifunctional linchpin reagents currently inaccessible using literature methods. Analogues are readily forged in two steps and in high yields from simple carboxylic acids or through

  双环[1.1.0]丁烷（BCB）是高度应变的碳环，已作为通用的合成工具出现，特别是用于功能化小分子的构建。这项工作报告了两种快速途径，可以快速制备20多种结构多样的BCB酮，包括简单的烷基和芳基衍生物，以及前所未有的氨基酸，二肽，生物等排物和双官能化的Linchpin试剂，目前尚无法通过文献方法获得。从简单的羧酸或通过不对称的酮合成开始，以方便的羰基取代等价物，可以很容易地分两步以高收率生产类似物。强调了这种新的应变亲电试剂盒对蛋白原性亲核试剂的选择性修饰的实用性。
• Cubanes in Medicinal Chemistry: Synthesis of Functionalized Building Blocks
  作者：Joanna Wlochal、Robert D. M. Davies、Jonathan Burton

  DOI：10.1021/ol501750k

  日期：2014.8.15

  cubane-1,4-dimethylester. A range of synthetic methods have been applied to prepare these cubane building blocks with one or two functional handles to allow easy incorporation into existing medicinal chemistry programs.

  从可商购的古巴-1,4-二甲基酯制备了一系列新的，药学上相关的含古巴分子。已经应用了多种合成方法来制备具有一个或两个功能手柄的这些古巴构建基块，以使其易于并入现有的药物化学程序中。